I was honored to present at the @TIRO_expert-led tumor board, which brought together leaders in thyroid imaging, pathology, surgery, and endocrine care—moderated by Dr. Tuttle. Watch the full session:
https://t.co/xvmXdSdqxn
@TheEndoSociety Agree! I hope that this will facilitate the advancement of more comprehensive research and facilitate further discussions in the future.
Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process - The Lancet https://t.co/0IYd10haDU
An outstanding program and an important step forward in rare endocrine disease education @TheEndoSociety . I’m grateful to have joined this inaugural RED cohort #Endocrinology
We welcomed 45 fellows for the inaugural Rare Endocrine Disease Fellows (RED) Program. Fellows left more confident in genetic testing, interpretation, and patient‑centered care. On‑demand learning launches this summer. https://t.co/2E32czkprx @RareDiseases#Endocrinology
We welcomed 45 fellows for the inaugural Rare Endocrine Disease Fellows (RED) Program. Fellows left more confident in genetic testing, interpretation, and patient‑centered care. On‑demand learning launches this summer. https://t.co/2E32czkprx @RareDiseases#Endocrinology
NEW pilot-grant program! 🔬 ATA is funding 15 early-career investigators with up to $10K for innovative thyroid research. Applications due May 15. Associate & Early Career Members—this is your opportunity! Apply: https://t.co/6BWjoSdfiF
#ThyroidResearch#ResearchGrant#ATA
I’m pleased to announce that I received the @TheEndoSociety outstanding abstract award for the year 2026 on my project highlighting the Biochemical Activity and Metastatic Profile for patients with MEN2A with RET C609Y!!
🏆 📄
https://t.co/j5wNprh7Uq
🆕Article out now.
💡Highlighting a non-invasive method to monitor systemic physiological shifts during #cancer therapy.
📖Read More:
https://t.co/FZW6qjFwSd
✏️From Authors at @YaleMed and the lab of Prof. Barbara Ehrlich including @eiman_md
My work with @ADA_DiabetesPro, highlighting the barriers to inclusive clinical trials for diabetes among people with diabetes and their caregivers,
Thank you, @nuhaaelsayed, for mentorship
https://t.co/4wz9Gc0ED9
New Voices of Wisdom: Dr. Zubair Baloch shares thyroid FNA pearls, what “adequate” really means, and where molecular testing and AI can help. https://t.co/St74fenoXZ #ThyroidCytology#ThyroidCancer